Aberrant activation of Notch signaling in human breast cancer

被引:458
作者
Stylianou, S
Clarke, RB
Brennan, K
机构
[1] Univ Manchester, Christie Hosp NHS Trust, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England
[2] Univ Manchester, Christie Hosp NHS Trust, Canc Res UK, Dept Med Oncol, Manchester M13 9PT, Lancs, England
基金
英国惠康基金;
关键词
D O I
10.1158/0008-5472.CAN-05-3054
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A role for Notch signaling in human breast cancer has been suggested by both the development of adenocarcinomas in the murine mammary gland following pathway activation and the loss of Numb expression, a negative regulator of the Notch pathway, in a large proportion of breast carcinomas. However, it is not clear currently whether Notch signaling is frequently activated in breast tumors, and how it causes cellular transformation. Here, we show accumulation of the intracellular domain of Notch1 and hence increased Notch signaling in a wide variety of human breast carcinomas. In addition, we show that increased RBP-J kappa-dependent Notch signaling is sufficient to transform normal breast epithelial cells and that the mechanism of transformation is most likely through the suppression of apoptosis. More significantly, we show that attenuation of Notch signaling reverts the transformed phenotype of human breast cancer cell lines, suggesting that inhibition of Notch signaling may be a therapeutic strategy for this disease.
引用
收藏
页码:1517 / 1525
页数:9
相关论文
共 40 条
[1]   CSL-independent Notch signalling: a checkpoint in cell fate decisions during development? [J].
Arias, AM ;
Zecchini, V ;
Brennan, K .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (05) :524-533
[2]   Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[3]   Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress [J].
Buschmann, T ;
Potapova, O ;
Bar-Shira, A ;
Ivanov, VN ;
Fuchs, SY ;
Henderson, S ;
Fried, VA ;
Minamoto, T ;
Alarcon-Vargas, D ;
Pincus, MR ;
Gaarde, WA ;
Holbrook, NJ ;
Shiloh, Y ;
Ronai, Z .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (08) :2743-2754
[4]   BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis [J].
Cheng, EHYA ;
Wei, MC ;
Weiler, S ;
Flavell, RA ;
Mak, TW ;
Lindsten, T ;
Korsmeyer, SJ .
MOLECULAR CELL, 2001, 8 (03) :705-711
[5]   Involvement of Notch1 in the development of mouse mammary tumors [J].
Diévart, A ;
Beaulieu, N ;
Jolicoeur, P .
ONCOGENE, 1999, 18 (44) :5973-5981
[6]   Notch signaling and inherited disease syndromes [J].
Gridley, T .
HUMAN MOLECULAR GENETICS, 2003, 12 :R9-R13
[7]   F3/contactin acts as a functional ligand for notch during oligodendrocyte maturation [J].
Hu, QD ;
Ang, BT ;
Karsak, M ;
Hu, WP ;
Cui, XY ;
Duka, T ;
Takeda, Y ;
Chia, W ;
Sankar, N ;
Ng, YK ;
Ling, EA ;
Maciag, T ;
Small, D ;
Trifonova, R ;
Kopan, R ;
Okano, H ;
Nakafuku, M ;
Chiba, S ;
Hirai, H ;
Aster, JC ;
Schachner, M ;
Pallen, CJ ;
Watanabe, K ;
Xiao, ZC .
CELL, 2003, 115 (02) :163-175
[8]  
Ilic D, 1998, J CELL BIOL, V143, P547
[9]   Identification of a novel NOTCH-4/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines [J].
Imatani, A ;
Callahan, R .
ONCOGENE, 2000, 19 (02) :223-231
[10]  
JANG MS, 2000, J CELL PHYSL, V199, P418